| qPCR | is used as | standard for diagnostics of SARS-CoV-2 (count: 1) | |
|---|---|
| Currently, real-time qPCR (RT-qPCR) is used as the gold standard for diagnostics of SARS-CoV-2.
-- reference not found! | |
| RT-qPCR | plays role as | standard method of diagnostics of SARS-CoV-2 (count: 1) | |
| RT-qPCR, as the standard method of diagnostics of SARS-CoV-2, plays an important role in this outbreak, though a low positive rate has been reported (5) .
-- reference not found! | |
| dPCR | reduces | false rate of diagnostics of SARS-CoV-2 (count: 1) | |
| This work demonstrates that dPCR significantly improves accuracy and reduces the false negative rate of diagnostics of SARS-CoV-2, which could be a powerful complement to the current RT-qPCR.
-- reference not found! | |
| SARS-CoV-2 sequencing | developing | diagnostics (count: 1) | |
| Ongoing SARS-CoV-2 sequencing is key to developing and monitoring diagnostics and similar surveillance tools.
-- CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design. biorxiv. 2020-03-02. | |
| efforts | develop diagnostics | fight against COVID-19 (count: 1) | |
| While the world are jointing efforts to develop diagnostics, therapeutics, and vaccines to fight against COVID-19, information about cultivation, purification and super molecular structure of SARS-CoV-2 in their native state is in need urgently.
-- Viral Architecture of SARS-CoV-2 with Post-Fusion Spike Revealed by Cryo-EM. biorxiv. 2020-03-05. | |
| S1 | is antigen for | SARS-CoV-2 diagnostics (count: 1) | |
| Therefore, consistent with our earlier findings for MERS-CoV serology (6), S1 is a specific antigen for SARS-CoV-2 diagnostics.
-- reference not found! | |
| capacity specifics | related to | 2019-nCoV diagnostics (count: 1) | |
| A questionnaire was designed to assess the capacity, quality and operational specifics related to 2019-nCoV diagnostics, as well as barriers against their implementation in laboratories that are part of the European Centre for Disease Control and Prevention (ECDC)-associated European expert laboratory network for emerging viral diseases (EVD-LabNet) and/or the European Reference Laboratory Network for Human Influenza (ERLI-Net).
| |
| responding laboratories | had implemented | diagnostics for 2019-nCoV (count: 1) | |
| At the laboratory level, 38 of 47 responding laboratories had implemented molecular diagnostics for 2019-nCoV at survey submission, and eight of the nine remaining laboratories planned to have tests implemented by mid-February 2020 ( Figure 2 ).
| |
| supports | need for | availability of diagnostics for panel of pathogens including SARS-CoV-2 (count: 1) | |
| Furthermore, it clearly shows that diagnosis of respiratory viruses cannot be done syndrome-based and supports the need for the availability of diagnostics for a panel of pathogens including SARS-CoV-2.
-- reference not found! | |
| diagnostics | is role in | battle to SARS-CoV-2 (count: 1) | |
| Viral diagnostics is an important role in this battle to SARS-CoV-2.
-- reference not found! | |